Retraction: A Novel Combination of Chinese Medicines to Treat Advanced Cancers and Lymphomas Tested in Rats

Chinese Medicine - United Kingdom
doi 10.1186/1749-8546-5-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

High-Throughput Genomics and Clinical Outcome in Hard-To-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Cancer Discovery
Oncology
2017English

Optimizing Arginine Deprivation for Hard-To-Treat Cancers

Oncotarget
Oncology
2017English

Chinese Herbal Medicines

Nutrition Reviews
MedicineNutritionDietetics
2009English

A Phase I Trial Investigating Pulsatile Erlotinib in Combination With Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancers

Investigational New Drugs
OncologyPharmacology
2016English

Synthetic Lethal Screens as a Means to Understand and Treat MYC-Driven Cancers

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Medicines for Cancers in Children: The WHO Model for Selection of Essential Medicines

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2015English

Novel Chemoradiotherapy Regimens Incorporating Targeted Therapies in Locally Advanced Head and Neck Cancers

2012English

How I Treat Cancers of Unknown Primary

ESMO Open
Cancer ResearchOncology
2019English

How We Treat Germ Cell Cancers

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy